On October 27, ASE responded to the Office of Science and Technology Policy’s (OSTP) Request for Information on AI Regulatory Reform. ASE outlined the Society’s core principle to require physicians to maintain oversight of all AI used in clinical decision-making, with no auto-finalization, immediate override controls, and continuous monitoring. The Society also outlined additional regulatory reforms to accelerate safe, equitable AI adoption in cardiovascular imaging and across U.S. healthcare.
Publishing date
October 27, 2025
Related Resources
Advocacy
ASE Joins Letter of Support for the Protecting Approved Care Act
On October 23, ASE joined the Alliance of...
Advocacy
ASE Joins Coalition Letter Urging Timely FY 2027 NIH Appropriations
On October 22, ASE joined 393 other organizations...
Advocacy
ASE Submits Comments on FDA’s GenAI-Enabled Medical Device Discussion Paper
On October 16, ASE submitted comments to the...